Cantitate/Preț
Produs
Total produse
Vezi coșul
An Introduction to Generative Drug Discovery de Sean Ekins

An Introduction to Generative Drug Discovery: Drugs and the Pharmaceutical Sciences

Editat de Sean Ekins
en Limba Engleză Hardback – 15 ian 2025
This book focuses on the latest advances in computational de novo drug discovery methods, also known as generative drug discovery. This book describes the state-of-the-art methods and applications for de novo design of drug candidates using generative chemistry models as well as ethical aspects of this technology.
Citește tot Restrânge

Din seria Drugs and the Pharmaceutical Sciences

Preț: 62607 lei

Preț vechi: 83962 lei
-25% Nou

Puncte Express: 939
Preț estimativ în valută:
11981€ • 12482$ • 9962£

Carte nepublicată încă


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032506234
ISBN-10: 1032506237
Pagini: 240
Ilustrații: 120
Dimensiuni: 156 x 234 mm
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences

Locul publicării:Boca Raton, United States

Public țintă

Academic, Postgraduate, and Professional Practice & Development

Cuprins

Front Pages. List of Contributors. Preface. Acknowledgments Part I – Introduction to Generative Chemical DesignGoing Beyond Serendipity: Generative Artificial Intelligence for Drug DiscoveryGenerative Drug Discovery Part II - Generative Chemical Models Based on Language ProcessingDe novo Drug Design by Chemical Language Modeling Part III - Generative Models and Synthetic AccessibilitySynthesis-based design — A Practical and Generalizable Approach to de novo Molecular DiscoveryA Medicinal Chemistry Perspective on Generative AIMegaSyn for Generative Molecule Design Part IV - From Models to PracticeGenerative Topographic Mapping of Chemical Space in de novo DesignIn Silico ADME/Tox in the Generative AI ParadigmThe Dark Side - Dual Use Implications of Generative Drug Discovery Part V – The FutureFuture Labs – Generative Approaches in Self Driving LabsThe Future of Generative Drug Discovery. Index.

Notă biografică

Sean Ekins is founder and CEO of Collaborations Pharmaceuticals, Inc. (CPI) which is focused on using machine learning approaches for rare and neglected disease drug discovery. Sean graduated from the University of Aberdeen, receiving his M.Sc., Ph.D. in Clinical Pharmacology and D.Sc. in Science. He was a postdoctoral fellow at Eli Lilly, before working as a senior scientist at Pfizer and then returning to Eli Lilly. He went on to join several startup companies at increasingly senior levels. Since 2005 he has been awarded numerous grants as PI for a wide array of start-up companies totaling over $12.2M as well as performing as a consultant on others. Since 2016 he has additionally won over 20 additional grants from NIH and DOD (STTR/SBIR grants, R21, UH2 and R01) totaling over $21.2M for CPI. He has a passion for advancing new technologies for drug discovery and is a prolific collaborator. He has authored or co-authored over 370 peer reviewed papers, book chapters, edited 5 books on different aspects of drug discovery research and topics and written one book on winning grants. Coverage of his recent research has also appeared in the Economist, Financial Times, Washington Post, Wired, Scientific American, CNN and Netflix as well as several podcasts. When he is not writing he enjoys cycling and record collecting.

Descriere

This book focuses on the latest advances in computational de novo drug discovery methods, also known as generative drug discovery. This book describes the state-of-the-art methods and applications for de novo design of drug candidates using generative chemistry models as well as ethical aspects of this technology.